Skip to main content
. 2022 Apr 10;14(8):1911. doi: 10.3390/cancers14081911
AR androgen receptor
ARE androgen-response element
AR-Vs androgen receptor variants
AR-FL full-length AR
AR-NTD AR N-terminal domain
CE3 cryptic exon 3
CLIP cross-linked RNA-immunoprecipitation
CRPC castration-resistant prostate cancer
DBD DNA-binding domain
ELAVL1/2 ELAV-like protein 1/2
hnRNP heterogeneous nuclear ribonucleoprotein
IGV integrative Genomic Viewer
LDB ligand-binding domain
NTD NH2-terminal transactivation domain
pre-mRNA precursor mRNA
PMN-MDSCs mature myeloid-derived suppressor cells
RBPs RNA-binding proteins
RNA pol II CTD C-terminal domain of RNA polymerase II
RRM RNA recognition motif
ssRNA oligo thirty-mer ssRNA labeled with biotin at the 5′ end
TRE TR3 response element